Lipowska Malgorzata, Cini Renzo, Tamasi Gabriella, Xu Xiaolong, Taylor Andrew T, Marzilli Luigi G
Department of Radiology, Emory University, Atlanta, Georgia 30322, USA.
Inorg Chem. 2004 Nov 29;43(24):7774-83. doi: 10.1021/ic049544i.
Radiopharmaceuticals containing the "fac-[M(CO)3]+ " core (M=99mTc, 186Re, or 188Re) have potential as diagnostic or therapeutic agents. Complexes with this core with sp3 amine donors have received little attention. We have studied adducts formed by ENDACH2 (HO2CCH2NHCH2CH2NHCH2CO2H) and ENACH (NH2CH2CH2NHCH2CO2H). Re(CO)3(ENDACH)-A (1A) and Re(CO)3(ENDACH)-B (1B) isomers were obtained by the reaction of ENDACH2 with Re(CO)5Cl. Re(CO)3(ENAC) (2) was obtained by the reaction of ENACH with aqueous [Re(CO)3(H2O)3]+. From single-crystal X-ray data, the three new neutral complexes, 1A, 1B, and 2, have a six-coordinate, pseudo-octahedral Re center with facially coordinated carbonyl ligands. ENDACH- and ENAC- bind facially to Re through both amine nitrogens and one carboxyl oxygen, forming two five-membered chelate rings. The Re(CO)3(ENDACH) isomers have an uncoordinated, dangling -CH2CO2H group, which is an ideal coupling site for attachment to biomolecules. The isomers differ by the configuration of the NH center bearing this dangling group. The H atom of the amine (N2) is endo (near the carbonyl ligands in the basal plane) in 1A and exo (away from carbonyl ligands) in isomer 1B. Isomers reach equilibrium (1A:1B, 70:30) after 3 days at high pH. Density functional structure optimizations were performed for isolated molecules of the type Tc(I)/Re(I)(CO)3(N2O): [Re(CO)3(NH3)2(H2O)]+, [Tc(CO)3(NH3)2(H2O)]+, [Re(CO)3(EN)(H2O)]+ (EN, ethylenediamine), [Tc(CO)3(EN)(H2O)]+, and various models for 1A, 1B, and 2. The computed structures are in good agreement with the X-ray structures. The theoretical and experimental Re-N bond distances usually agree within 0.045 A. The total electronic energy values for the computed 1A and 1B models differ by 0.815 kcal mol(-1), giving an isomer ratio of 80:20, in good agreement with the 1A/1B ratio (70:30) found.
含有“fac-[M(CO)₃]⁺ ”核心(M = ⁹⁹ᵐTc、¹⁸⁶Re或¹⁸⁸Re)的放射性药物有作为诊断或治疗剂的潜力。含有sp³胺供体的此类核心配合物很少受到关注。我们研究了由ENDACH₂(HO₂CCH₂NHCH₂CH₂NHCH₂CO₂H)和ENACH(NH₂CH₂CH₂NHCH₂CO₂H)形成的加合物。通过ENDACH₂与Re(CO)₅Cl反应得到了Re(CO)₃(ENDACH)-A(1A)和Re(CO)₃(ENDACH)-B(1B)异构体。通过ENACH与水溶液中的[Re(CO)₃(H₂O)₃]⁺反应得到了Re(CO)₃(ENAC)(2)。从单晶X射线数据可知,这三种新的中性配合物1A、1B和2具有六配位、伪八面体的Re中心,羰基配体呈面式配位。ENDACH-和ENAC-通过两个胺氮原子和一个羧基氧原子面式结合到Re上,形成两个五元螯合环。Re(CO)₃(ENDACH)异构体有一个未配位的、悬垂的-CH₂CO₂H基团,这是连接生物分子的理想偶联位点。异构体因带有这个悬垂基团的NH中心的构型不同而不同。胺(N₂)的H原子在1A中是endo(靠近基面中的羰基配体),在异构体1B中是exo(远离羰基配体)。在高pH下3天后异构体达到平衡(1A:1B,70:30)。对Tc(I)/Re(I)(CO)₃(N₂O)类型的孤立分子进行了密度泛函结构优化:[Re(CO)₃(NH₃)₂(H₂O)]⁺、[Tc(CO)₃(NH₃)₂(H₂O)]⁺、[Re(CO)₃(EN)(H₂O)]⁺(EN,乙二胺)、[Tc(CO)₃(EN)(H₂O)]⁺以及1A、1B和2的各种模型。计算得到的结构与X射线结构吻合良好。理论和实验得到的Re-N键长通常在0.045 Å范围内一致。计算得到的1A和1B模型的总电子能量值相差0.815 kcal mol⁻¹,异构体比例为80:20,与所发现的1A/1B比例(70:30)吻合良好。